Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Patterns of healthcare utilization by COPD severity: a pilot study.

Joo MJ, Lee TA, Bartle B, van de Graaff WB, Weiss KB.

Lung. 2008 Sep-Oct;186(5):307-12. doi: 10.1007/s00408-008-9095-5. Epub 2008 May 8.

PMID:
18463921
2.

Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.

Murphy DE, Panos RJ.

Int J Chron Obstruct Pulmon Dis. 2013;8:199-208. doi: 10.2147/COPD.S39555. Epub 2013 Apr 18.

3.

Comparison of Australian and international guidelines for grading severity of chronic obstructive pulmonary disease.

Kyoong A, Mol S, Guy P, Finlay P, Strauss BJ, Holmes P, Bardin PG.

Intern Med J. 2006 Aug;36(8):506-12.

PMID:
16866655
4.

Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.

Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT.

Chron Respir Dis. 2009;6(2):75-80. doi: 10.1177/1479972308101551.

PMID:
19411567
5.

Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?

Vestbo J, Lange P.

Am J Respir Crit Care Med. 2002 Aug 1;166(3):329-32.

PMID:
12153965
6.

Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea.

Chung K, Kim K, Jung J, Oh K, Oh Y, Kim S, Kim J, Kim Y.

BMC Pulm Med. 2014 Feb 27;14:27. doi: 10.1186/1471-2466-14-27.

7.

Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.

Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT.

Int J Chron Obstruct Pulmon Dis. 2011;6:573-81. doi: 10.2147/COPD.S16975. Epub 2011 Nov 9.

8.

Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.

Mapel DW, Dalal AA, Johnson PT, Becker LK, Hunter AG.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86. doi: 10.2147/COPD.S78827. eCollection 2015.

9.

Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.

Franssen FM, Spruit MA, Wouters EF.

Int J Chron Obstruct Pulmon Dis. 2011;6:493-501. doi: 10.2147/COPD.S24443. Epub 2011 Sep 26.

10.

Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?

Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU.

Chest. 2006 Oct;130(4):1117-28.

PMID:
17035446
11.

The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation.

Huijsmans RJ, de Haan A, ten Hacken NN, Straver RV, van't Hul AJ.

Respir Med. 2008 Jan;102(1):162-71. Epub 2007 Sep 18.

12.

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.

Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D.

Int J Chron Obstruct Pulmon Dis. 2012;7:201-9. doi: 10.2147/COPD.S25805. Epub 2012 Mar 15.

13.

Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.

Lee JY, Chon GR, Rhee CK, Kim DK, Yoon HK, Lee JH, Yoo KH, Lee SH, Lee SY, Kim TE, Kim TH, Park YB, Hwang YI, Kim YS, Jung KS.

J Korean Med Sci. 2016 Apr;31(4):553-60. doi: 10.3346/jkms.2016.31.4.553. Epub 2016 Mar 10.

14.

Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study.

Maleki-Yazdi MR, Lewczuk CK, Haddon JM, Choudry N, Ryan N.

COPD. 2007 Dec;4(4):313-20.

PMID:
18027158
15.

Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization.

Johannessen A, Nilsen RM, Storebø M, Gulsvik A, Eagan T, Bakke P.

Am J Respir Crit Care Med. 2013 Jul 1;188(1):51-9. doi: 10.1164/rccm.201212-2276OC.

PMID:
23590268
16.
17.

Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers.

Bajc M, Markstad H, Jarenbäck L, Tufvesson E, Bjermer L, Jögi J.

Ann Nucl Med. 2015 Jan;29(1):91-9. doi: 10.1007/s12149-014-0913-y. Epub 2014 Oct 15.

18.

The effect of comorbidities on COPD assessment: a pilot study.

Weinreich UM, Thomsen LP, Bielaska B, Jensen VH, Vuust M, Rees SE.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 25;10:429-38. doi: 10.2147/COPD.S76124. eCollection 2015.

19.

Do GOLD stages of COPD severity really correspond to differences in health status?

Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F; SaRA Investigators.

Eur Respir J. 2003 Sep;22(3):444-9.

20.

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.

Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:889-904. doi: 10.2147/COPD.S62750. eCollection 2014.

Supplemental Content

Support Center